03.31.2022 - By ReachMD
Host: Jennifer Caudle, DO
Guest: Richard S. Lemons, MD, PHD
Guest: Robert Klamroth, MD, PhD
Factor replacement therapy is commonly used to treat hemophilia B, but could gene therapy be a useful alternative? Dr. Jennifer Caudle joins Dr. Robert Klamroth from the Vivantes Friedrichshain Hospital in Berlin, Germany, and Dr. Richard S. Lemons from the University of Utah Huntsman Cancer Institute to share their clinical trial experience with gene therapy in patients with hemophilia B.